TILOS THERAPEUTICS, INC.

Profile

Company Names

TILOS THERAPEUTICS, INC.

Addresses

C/O LABCENTRAL, 700 MAIN STREET, NORTH, CAMBRIDGE, MA 02139

C/O FABER DAEUFER + ITRATO PC, 890 WINTER STREET, SUITE 315, WALTHAM, MA 02451

Phone Numbers

508-233-3923
617-795-4700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$3,800,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-09-13 
$3,050,000.00 
$4,050,000.00 
$1,000,000.00 
Equity 
1
2016-08-19 
$750,000.00 
$1,500,000.00 
$750,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
EDWARDS 
EXECUTIVE OFFICER, DIRECTOR
MOVE NETWORKS INC   |  PERMEON BIOLOGICS, INC.   |  MACULOGIX, INC.   |  AVAXIA BIOLOGICS, INC   |  IMMUNEXCITE, INC.   |  RENOVA PCA, LLC   |  TILOS THERAPEUTICS, INC.   |  ABCURO, INC.   |  PANTHER THERAPEUTICS, INC.
BARBARA 
 
FOX 
EXECUTIVE OFFICER, DIRECTOR
TILOS THERAPEUTICS, INC.   |  ALPHINA THERAPEUTICS, INC.
MARTIN 
 
HEIDECKER 
DIRECTOR
ARMAGEN TECHNOLOGIES INC   |  SENTIEN BIOTECHNOLOGIES, INC.   |  TILOS THERAPEUTICS, INC.   |  ABEXXA BIOLOGICS, INC.   |  ARMAGEN, INC.   |  RGENTA THERAPEUTICS, INC.   |  VENATORX PHARMACEUTICALS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  ADAPTIVE PHAGE THERAPEUTICS, INC.   |  ELION THERAPEUTICS, INC.
ROGER 
 
KITTERMAN 
DIRECTOR
DAKTARI DIAGNOSTICS, INC.   |  VISIONSCOPE TECHNOLOGIES LLC   |  COSTIM PHARMACEUTICALS INC.   |  TILOS THERAPEUTICS, INC.   |  PARTNERS INNOVATION FUND II, L.P.   |  ALBAMUNITY, INC.   |  CODAMETRIX INC.
JULIUS 
 
KNOWLES 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  TILOS THERAPEUTICS, INC.   |  PARTNERS INNOVATION FUND II, L.P.   |  ABCURO, INC.   |  PROXIMITY THERAPEUTICS, INC.   |  65 THERAPEUTICS, INC.   |  20 BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-09-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-13 
2016-09-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#